Spero Therapeutics to Present Company Update and Report Fourth Quarter and Full-Year 2020 Monetary Success on Thursday, March 11, 2021

CAMBRIDGE, Mass., March 03, 2021 (World NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical corporation centered on identifying, building and commercializing therapies